CIM
CCLA Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $129K | Buy |
317,881
+50,695
| +19% | +$20.5K | 0.1% | 25 |
|
|
2025
Q1 | $133M | Buy |
267,186
+8,615
| +3% | +$4.29M | 2.35% | 15 |
|
|
2024
Q4 | $134M | Buy |
258,571
+8,985
| +4% | +$4.67M | 2.13% | 19 |
|
|
2024
Q3 | $137M | Hold |
249,586
| – | – | 2.12% | 11 |
|
|
2024
Q2 | $137M | Buy |
249,586
+2,493
| +1% | +$1.37M | 2.12% | 11 |
|
|
2024
Q1 | $143M | Buy |
247,093
+2,024
| +0.8% | +$1.17M | 2.2% | 10 |
|
|
2023
Q4 | $131M | Buy |
245,069
+63,401
| +35% | +$33.8M | 2.14% | 13 |
|
|
2023
Q3 | $92M | Buy |
181,668
+21,594
| +13% | +$10.9M | 1.72% | 25 |
|
|
2023
Q2 | $83.4M | Buy |
160,074
+17,399
| +12% | +$9.07M | 1.49% | 32 |
|
|
2023
Q1 | $82.1M | Sell |
142,675
-582
| -0.4% | -$335K | 1.61% | 28 |
|
|
2022
Q4 | $78.9M | Sell |
143,257
-615
| -0.4% | -$339K | 1.78% | 24 |
|
|
2022
Q3 | $73.2M | Buy |
+143,872
| New | +$73.2M | 1.77% | 24 |
|
|
2022
Q1 | $93.3M | Buy |
157,721
+8,182
| +5% | +$4.84M | 1.68% | 26 |
|
|
2021
Q4 | $99.8M | Sell |
149,539
-9,503
| -6% | -$6.34M | 1.64% | 31 |
|
|
2021
Q3 | $90.9M | Buy |
159,042
+975
| +0.6% | +$557K | 1.51% | 32 |
|
|
2021
Q2 | $79.8K | Buy |
158,067
+86
| +0.1% | +$43 | 0.97% | 38 |
|
|
2021
Q1 | $72.2M | Sell |
157,981
-29,431
| -16% | -$13.4M | 1.44% | 35 |
|
|
2020
Q4 | $87M | Sell |
187,412
-14,308
| -7% | -$6.64M | 1.96% | 22 |
|
|
2020
Q3 | $89M | Sell |
201,720
-5,704
| -3% | -$2.52M | 2.41% | 12 |
|
|
2020
Q2 | $75.1M | Buy |
+207,424
| New | +$75.1M | 2.35% | 13 |
|